Researchers advance scalable stem-cell bioprocessing with AI-enabled manufacturing for regenerative medicine therapies.

Knowing which stem cell characteristics to optimize during the manufacturing process is among the biggest challenges still facing the cell therapy industry. That’s according to Greg Fiore, MD, CEO of ...

"This means that we more like closed the gap for the first stage," Xie says. To support large-scale manufacturing, the scientists use suspension bioreactors, or vessels that sustain a biologically ...

Chimeric antigen receptor (CAR) -T-cell therapies have yielded remarkable results in the treatment of hematological malignancies. Several autologous CAR T-cell products have received marketing ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford ...